Clinical Trials Directory

Trials / Completed

CompletedNCT05189249

Determinant of Repeat Revascularization After Percutaneous Coronary Intervention

Determinant of Repeat Revascularization Within 5 Years of Percutaneous Coronary Intervention at a Tertiary Care Hospital, Karachi: A Matched Case-Control Study

Status
Completed
Phase
Study type
Observational
Enrollment
270 (actual)
Sponsor
Aga Khan University · Academic / Other
Sex
Female
Age
25 Years
Healthy volunteers
Not accepted

Summary

To determine factors associated with repeat revascularization among adults aged 25 years and above within 5 years of first Percutaneous Coronary Intervention (PCI) at a tertiary care hospital.

Detailed description

Matched case-control study design was employed to determine the association between re-peat revascularization and its determinants in patients within 5 years of undergoing index PCI. The case was defined as a patient who had undergone repeat revascularization within 5 years of undergoing index PCI. Control was defined as a patient who had not undergone repeat revascularization within 5 years of undergoing index PCI. The retrospective study was carried out with the approval of the Ethical Review Committee of the tertiary care hospital where the study was carried out. A waiver of informed consent was granted as this was a retrospective study and all patients were discharged from the hospital. A minimum of 120 cases with matched 240 controls were required in 1:2 case to control ratio. This sample size was essential to achieve the power of 80% for an anticipated matched odds ratio of 2 with the hypothesized correlation of 0.2 using a two-sided hypothesis test with a significance level of 0.05. The outcome of the study was the Repeat revascularization status. There are different types of repeat revascularization according to the site and lesion to which intervention has been provided. Any type of repeat revascularization was considered and enrolled as a case in this study5. Covariates included in the study were divided into patient characteristics (gender, age, health coverage, BMI, smoking status), comorbidity status (Hypertension, Diabetes Mellitus, Hyperlipidaemia, valvular disease), clinical characteristics (Creatinine level, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, Cholesterol level, other technical factors related to the index PCI) and medication status (Beta-blocker, ACE Inhibitor, Statin).

Conditions

Interventions

TypeNameDescription
OTHERNo intervention performedNo intervention performed. Participants were enrolled retrospectively and medical records were accessed for data.

Timeline

Start date
2018-01-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2022-01-12
Last updated
2023-07-24

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05189249. Inclusion in this directory is not an endorsement.